Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• Huang Z, Hu Y, Hua D, Wu Y, Song M, Cheng Z. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma. Exp Mol Pathol. 2011;91:702–707. doi:10.1016/j.yexmp.2011.08.00421884695
   PubMed Web of Science ®Google Scholar
• Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology. 2008;47:908–998. doi:10.1002/hep.2211018161048
   PubMed Web of Science ®Google Scholar
• Wong IH, Johnson PJ, Lai PB, Lau WY, Lo YM. Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients: implications for cancer detection and monitoring. Ann N Y Acad Sci. 2000;906:102–105. doi:10.1111/j.1749-6632.2000.tb06598.x10818604
   PubMed Web of Science ®Google Scholar
• Toh TB, Lim JJ, Chow EK. Epigenetics of hepatocellular carcinoma. Clin Transl Med. 2019;8:13. doi:10.1186/s40169-019-0230-031056726
   PubMed Web of Science ®Google Scholar
• Saintigny P, Zhang L, Fan YH, et al. Gene expression profiling predicts the development of oral cancer. Cancer Prev Res (Phila). 2011;4:218–229. doi:10.1158/1940-6207.CAPR-10-015521292635
   PubMed Web of Science ®Google Scholar
• Li XQ, Guo YY, De W. DNA methylation and microRNAs in cancer. World J Gastroenterol. 2012;18:882–888. doi:10.3748/wjg.v18.i9.88222408346
   PubMed Web of Science ®Google Scholar
• Calvisi DF, Ladu S, Gorden A, et al. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest. 2007;117:2713–2722. doi:10.1172/JCI3145717717605
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Wu HC, Shen J, et al. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin Cancer Res. 2007;13:2378–2384. doi:10.1158/1078-0432.CCR-06-190017438096
   PubMed Web of Science ®Google Scholar
• Wong IHN, Lo YMD, Zhang J, et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 1999;59:71–73.9892188
   PubMed Web of Science ®Google Scholar
• Yeo W, Wong N, Wong WL, Lai PB, Zhong S, Johnson PJ. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. Liver Int. 2005;25:266–272. doi:10.1111/j.1478-3231.2005.01084.x15780049
   PubMed Web of Science ®Google Scholar
• Wang J, Qin Y, Li B, Sun Z, Yang B. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clin Biochem. 2006;39(4):344–348. doi:10.1016/j.clinbiochem.2006.01.00816527261
   PubMed Web of Science ®Google Scholar
• Colombo M. Screening for cancer in viral hepatitis. Clin Liver Dis. 2001;5(1):109–122. doi:10.1016/S1089-3261(05)70156-211218910
   PubMedGoogle Scholar
• Li L, Zhao H, Chen B, et al. Noninvasive identification of immune-related biomarkers in hepatocellular carcinoma. J Oncol. 2019;2019:2531932. doi:10.1155/2019/253193231531018
   PubMed Web of Science ®Google Scholar
• Li L, Choi JY, Lee KM, et al. DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology. J Epidemiol. 2012;22:384–394. doi:10.2188/jea.JE2012000322863985
   PubMed Web of Science ®Google Scholar
• Wong IH, Zhang J, Lai PB, Lau WY, Lo YM. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. Clin Cancer Res. 2003;9:1047–1052.12631605
   PubMed Web of Science ®Google Scholar
• Narimatsu T, Tamori A, Koh N, et al. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Intervirology. 2004;47:26–31. doi:10.1159/00007663915044833
   PubMed Web of Science ®Google Scholar
• Katoh H, Shibata T, Kokubu A, et al. Epigenetic instability and chromosomal instability in hepatocellular carcinoma. Am J Pathol. 2006;168:1375–1384. doi:10.2353/ajpath.2006.05098916565510
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649. doi:10.1002/bjs.18006008174541913
   PubMed Web of Science ®Google Scholar
• Wiesner RH, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–96. doi:10.1053/gast.2003.5001612512033
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022. doi:10.1002/hep.2419921374666
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JG, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821–9826. doi:10.1073/pnas.93.18.98218790415
   PubMed Web of Science ®Google Scholar
• Wong IHN, Lo YMD, Yeo W, Lau WY, Johnson PJ. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res. 2000;6:3516–3521.10999738
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101–1108. doi:10.1038/nprot.2008.7318546601
   PubMed Web of Science ®Google Scholar
• Wang M, Ye Q, Mao D, Li H. Research progress in liver-regenerating microenvironment and DNA methylation in hepatocellular carcinoma: the role of traditional Chinese medicine. Med Sci Monit. 2020;26:e920310. doi:10.12659/MSM.92031032144233
   PubMed Web of Science ®Google Scholar
• Chu HJ, Heo J, Seo SB, et al. Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma. J Korean Med Sci. 2004;19:83–86. doi:10.3346/jkms.2004.19.1.8314966347
   PubMed Web of Science ®Google Scholar
• Shim YH, Yoon GS, Choi HJ, Chung YH, Yu E. p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis. Cancer Lett. 2003;190:213–219. doi:10.1016/S0304-3835(02)00613-412565176
   PubMed Web of Science ®Google Scholar
• Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994;79(4):551–555. doi:10.1016/0092-8674(94)90540-17954821
   PubMed Web of Science ®Google Scholar
• Zang JJ, Xie F, Xu JF, et al. P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis. World J Gastroenterol. 2011;17:3043–3048. doi:10.3748/wjg.v17.i25.304321799651
   PubMed Web of Science ®Google Scholar
• Zheng Y, Hlady RA, Joyce BT, et al. DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma. Clin Epigenetics. 2019;11(1):145. doi:10.1186/s13148-019-0733-y31639042
   PubMed Web of Science ®Google Scholar
• Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6:107–163. doi:10.1038/nrc179916491070
   PubMed Web of Science ®Google Scholar
• Toyota M, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Semin Oncol. 2005;32:521–530. doi:10.1053/j.seminoncol.2005.07.00316210093
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61:1659–1665.11245480
   PubMed Web of Science ®Google Scholar
• Lou C, Du Z, Yang B, Gao Y, Wang Y, Fang S. Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin. Cancer Sci. 2009;100:996–1004. doi:10.1111/j.1349-7006.2009.01138.x19385975
   PubMed Web of Science ®Google Scholar
• Li X, Hui AM, Sun L, et al. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res. 2004;10:7484–7489. doi:10.1158/1078-0432.CCR-04-171515569978
   PubMed Web of Science ®Google Scholar
• Wong IH, Lo YM, Lai PB, Johnson PJ. Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients. Clin Chem. 2000;46:1420–1422. doi:10.1093/clinchem/46.9.142010973879
   PubMed Web of Science ®Google Scholar
• Herath NI, Leggett BA, MacDonald GA. Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol. 2006;21:15–21. doi:10.1111/j.1440-1746.2005.04043.x16706806
   PubMed Web of Science ®Google Scholar
• Ganesan A, Arimondo PB, Rots MG, Jeronimo C, Berdasco M. The timeline of epigenetic drug discovery: from reality to dreams. Clin Epigenetics. 2019;11:174. doi:10.1186/s13148-019-0776-031791394
   PubMed Web of Science ®Google Scholar
• Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res. 2011;727(3):55–61. doi:10.1016/j.mrrev.2011.04.00121514401
   PubMed Web of Science ®Google Scholar